CS logo
small CS logo
ATTIKON University Hospital

Athens, Greece
Πανεπιστημιακό νοσοκομείο στο Χαϊδάρι

About ATTIKON University Hospital


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Attikon Hospital
21
University of Athens
19
Amgen
10
Hoffmann-La Roche
8
Boehringer Ingelheim
7
Takeda
6
Bayer
4
Celgene
4
National and Kapodistrian University of Athens
4
Inflammatix
2
Pfizer
2
Total Rows: 57

Clinical Trials at ATTIKON University Hospital


During the past decade, ATTIKON University Hospital conducted 107 clinical trials. In the 10-year time frame, 107 clinical trials started and 17 clinical trials were completed, i.e. on average, 15.9% percent of trials that started reached the finish line to date. In the past 5 years, 54 clinical trials started and 11 clinical trials were completed. i.e. 20.4% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years55771414121215151515252514140000223311004466Started TrialsCompleted Trails201520162017201820192020202120220102030
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension
2006-09-01
2013-08-01
Completed
105
To Assess The Efficacy and Safety Of Oral Sildenafil in the Treatment of Pulmonary Arterial Hypertension.
2008-04-08
2010-05-25
Terminated
130
Psoriasis Longitudinal Assessment and Registry
2007-06-21
2030-12-31
Recruiting
16,000
Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma
2008-08-21
2016-07-14
Completed
1,623
Strategic Timing of Antiretroviral Treatment
2009-04-15
2022-07-27
Completed
4,688
Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral naïve Subjects
2010-08-01
2013-10-01
Completed
800
Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers
2010-06-01
2014-05-01
Completed
167
Balloon Angioplasty Versus Primary Stenting for the Treatment of Femoropopliteal Artery Chronic Total Occlusions
2010-12-01
2016-12-01
Unknown status
150

Rows per page:

1–100 of 138

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "ATTIKON University Hospital" #1 sponsor was "Attikon Hospital" with 21 trials, followed by "University of Athens" with 19 trials sponsored, "Amgen" with 10 trials sponsored, "Hoffmann-La Roche" with 8 trials sponsored and "Boehringer Ingelheim" with 8 trials sponsored. Other sponsors include 68 different institutions and companies that sponsored additional 57 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "ATTIKON University Hospital" #1 collaborator was "Attikon Hospital" with 3 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "NEAT - European AIDS Treatment Network" with 2 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator and "Takeda Development Center Americas, Inc." with 2 trials as a collaborator. Other collaborators include 53 different institutions and companies that were collaborators in the rest 62 trials.
Created with Highcharts 11.1.0Top Leading SponsorsAttikon Hospital: 21Attikon Hospital: 21University of Athens: 19University of Athens: 19Amgen: 10Amgen: 10Hoffmann-La Roche: 8Hoffmann-La Roche: 8Boehringer Ingelheim: 7Boehringer Ingelheim: 7Takeda: 6Takeda: 6Bayer: 4Bayer: 4Celgene: 4Celgene: 4National andKapodistrian Universityof Athens: 4National andKapodistrian Universityof Athens: 4Inflammatix: 2Inflammatix: 2

Created with Highcharts 11.1.0Top CollaboratorsAttikon Hospital: 3Attikon Hospital: 3Merck Sharp & Dohme LLC: 2Merck Sharp & Dohme LLC: 2NEAT - European AIDSTreatment Network: 2NEAT - European AIDSTreatment Network: 2National Institute ofAllergy and InfectiousDiseases (NIAID): 2National Institute ofAllergy and InfectiousDiseases (NIAID): 2Takeda DevelopmentCenter Americas, Inc.:2Takeda DevelopmentCenter Americas, Inc.:2University Hospital of Patras: 2University Hospital of Patras: 2AHEPA University Hospital: 1AHEPA University Hospital: 1ANRS, EmergingInfectious Diseases: 1ANRS, EmergingInfectious Diseases: 1Abbott: 1Abbott: 1Acceleron Pharma Inc.(a wholly ownedsubsidiary of MerckSharp and Dohme, asubsidiary of Merck &Co., Inc.): 1Acceleron Pharma Inc.(a wholly ownedsubsidiary of MerckSharp and Dohme, asubsidiary of Merck &Co., Inc.): 1

Clinical Trials Conditions at ATTIKON University Hospital


According to Clinical.Site data, the most researched conditions in "ATTIKON University Hospital" are "Coronary Artery Disease" (5 trials), "Psoriasis" (4 trials), "Pulmonary Arterial Hypertension" (4 trials), "Atrial Fibrillation" (3 trials) and "COVID-19" (3 trials). Many other conditions were trialed in "ATTIKON University Hospital" in a lesser frequency.

Clinical Trials Intervention Types at ATTIKON University Hospital


Most popular intervention types in "ATTIKON University Hospital" are "Drug" (83 trials), "Other" (20 trials), "Device" (11 trials), "Diagnostic Test" (8 trials) and "Procedure" (8 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (31 trials), "Apremilast" (3 trials), "Cisplatin" (3 trials), "Soticlestat" (3 trials) and "Atezolizumab" (2 trials). Other intervention names were less common.

Clinical Trials Genders at ATTIKON University Hospital


The vast majority of trials in "ATTIKON University Hospital" are 134 trials for "All" genders and 4 trials for "Female" genders.

Clinical Trials Status at ATTIKON University Hospital


Currently, there are 57 active trials in "ATTIKON University Hospital". 1 are not yet recruiting, 38 are recruiting, 17 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 52 completed trials in ATTIKON University Hospital, undefined suspended trials, and 10 terminated clinical trials to date.
Out of the total trials that were conducted in ATTIKON University Hospital, 2 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 47 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 23 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 47Phase 3: 47Not Applicable: 23Not Applicable: 23Phase 2: 23Phase 2: 23Phase 4: 11Phase 4: 11Phase 1: 2Phase 1: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 52Completed: 52Recruiting: 38Recruiting: 38Unknown status: 18Unknown status: 18Active, not recruiting: 17Active, not recruiting: 17Terminated: 10Terminated: 10Enrolling by invitation: 1Enrolling by invitation: 1Not yet recruiting: 1Not yet recruiting: 1Withdrawn: 1Withdrawn: 1